Central administration of palmitoylethanolamide lessens hyperalgesia in mice by way of inhibition of NF‐κB nuclear signalling in dorsal root ganglia. Eur J Pharmacol All 3 studies are consistent with present literature on PEA’s considerable therapeutic index, that makes it an interesting candidate for the 1st line therapy of joint https://proleviate19321.blogozz.com/29888740/5-easy-facts-about-palmitoylethanolamide-described